Bryan R. Luce, PhD, MS, MBA, is Chief Executive Officer, L & M Strategic Outcomes LLC, an affiliate research professor at the University of Washington’s School of Pharmacy and a senior advisor to Evidera. Bryan has focused his career on developing and improving methods, policies and applications for evidence-based healthcare.
In his previous role as Chief Science Officer of the Patient-Centered Outcomes Research Institute, He was responsible for leading the development and implementation of PCORI’s patient-centered comparative clinical effectiveness research agenda. Bryan previously founded the outcomes research firm MEDTAP® International, serving as its Chairman, President, and Chief Executive Officer, and was the Senior Vice President for Science Policy at the United BioSource Corporation. Earlier, He was Director of Battelle’s Centers for Public Health Research and Evaluation; Director of the Office of Research and Demonstrations, Centers for Medicare and Medicaid Services; and a Senior Analyst at the Office of Technology Assessment of the United States Congress. His research has focused on improving methods and related policies for more efficient healthcare decision making. He has authored more than 100 scientific publications, including three textbooks on health technology assessment, health policy, and health economics.
In 2008, Bryan founded the Pragmatic Approaches to Comparative Effectiveness (PACE) Initiative, which studied novel methods to conduct analytical efficiency comparative effectiveness trials. Previously, he founded the Bayesian Initiative in Health Economics and Outcomes Research and presently chairs the Scientific Collaboration of EXCITE International, whose mission is to pioneer an international platform for coordinated market approval and market access of medical devices. He has been an advisor to numerous government and nonprofit agencies, as well as pharmaceutical and device firms worldwide; a member or chair of socioeconomic and public health policy advisory boards for leading biopharmaceutical companies; a member of the Medicare Evidence Development & Coverage Advisory Committee (MedCAC), and a member of the Board of Directors for the Medical Device Innovation Consortium (MDIC). Bryan is also a past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and in 2008 received the Society’s Avedis Donabedian Outcomes Research Lifetime Achievement Award. He has held adjunct faculty positions in the Department of Health Policy at Jefferson Medical College, the Leonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California, and the Department of Health Services, George Washington University.
A former Special Forces Officer, he is a Lieutenant Colonel (Retired), U.S. Army Reserves. He holds MS (public health) and MBA degrees from the University of Massachusetts at Amherst, and a PhD in health services research from the University of California at Los Angeles.
Marie E. Michnich, DrPH, is a national health policy strategist, senior executive and leadership coach, and educator who brings together health and medical care experience spanning clinical practice, health services research, federal legislative service, and public policy. She is the President of L & M Strategic Outcomes. Previously she served as the Senior Director of Health Policy Education Programs and Fellowships at the NAM for 15 years. In that role, she directed the Robert Wood Johnson Foundation Health Policy Fellows and the National Academy of Medicine Fellowships, and administered the Food and Drug Administration Tobacco Regulatory Science Fellowship and the Distinguished Nurse Scholar-in-Residence.
In 2007, Marie served as the Executive Director of the President's Commission on Care for America's Returning Wounded Warriors, Co-chaired by Senator Robert Dole and Secretary Donna Shalala. The Commission evaluated and made recommendations to improve the care of injured service members from the time when they are evacuated from the battlefield up to their return to active duty or civilian life. The 9 member Commission supported by 42 military and civilian staff, completed 23 site visits, 8 public meetings, 7 background papers and a survey of more than 1700 injured service members and veterans. The Commission presented a landmark report to the President recommending fundamental changes to the disability determination and compensation systems of the DoD and VA, and expansion and improvement of coordination of benefits and services for service members and their families. Report recommendations have been the basis for broad policy changes in DoD and VA and several legislative proposals.
Prior to her work at the National Academy of Medicine, Dr. Michnich served as a Senior Executive for both the Health Policy and the Clinical Practice and Scientific Services Divisions of the American College of Cardiology. She led the areas of public and private sector health policy and quality of care, including: development of clinical practice guidelines, clinical privileges, consensus statements and clinical alerts; performance and outcomes measures; clinical and data standards; research services; and scientific committee coordination and collaboration. Her accomplishments included creating nationally recognized programs and initiatives in state and federal government relations, coding and reimbursement, private sector relations, health policy research and public policy. During her tenure at the College, she spearheaded a joint effort of the American Heart Association and the College in the development of physician performance measures, and secured cardiology's role in coding and reimbursement policy through the production of the authoritative and highly successful coding manual, and positioning the specialty within the national forums with jurisdiction in these areas.
Marie came to Washington D. C. when she was awarded a Robert Wood Johnson Health Policy Fellowship and subsequently served as a legislative assistant to the United States Senate Majority Leader, Robert Dole (R-KS), for health policy, including Medicare, Medicaid, maternal and child health, and the Peer Review Organizations. Major legislative initiatives included graduate medical education reform, physician payment reform, catastrophic health insurance, and initial efforts to create a Medicare drug benefit. She was staff liaison to the Executive branch, House and Senate offices, as well as health professional and trade associations.
She began her health policy career as an assistant professor of Health Services, University of Washington in Seattle, Washington. She was co-principle investigator on over $1 million in federal grants in the areas of health promotion and disease prevention in ambulatory care and she taught courses on medical care organization, program evaluation, ambulatory care management, and health services research.
Marie has been an active member of several national health policy groups and has served as the editor of two news publications. From 1994 to 2001, she was a Board member, then Chair of the Health Care Quality Alliance, a national coalition of 100 organizations that joined to preserve quality of health care in the United States. She served on the Advisory Board of the Robert Wood Johnson Foundation Health Policy Fellows, a program she subsequently directed, and was elected as the first public member of the Board of Directors of the American Pharmacists Association Foundation. She currently serves on the Board of Pharmacy Specialties and the National Center for Healthcare Leadership.
Marie received her undergraduate degree from the University of Connecticut. She received her Masters in health services administration and Doctorate in health services research from the University of California, Los Angeles.
Expertise/Interests: Health Policy, Leadership Development, Government Relations